Long Acting Injectable Formulations - Infectious Diseases

Relevant Publications

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients.

Issue Release: 2024

Long-acting intramuscular injections of ELQ-331, an antimalarial agent.

Issue Release: 2024

Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study.

Issue Release: 2024

Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.

Issue Release: 2024

Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs.

Issue Release: 2024

Impact of blood meals taken on ivermectin-treated livestock on survival and egg production of the malaria vector Anopheles coluzzii under laboratory conditions.

Issue Release: 2024

Freezing-mediated formation of supraproteins using depletion forces.

Issue Release: 2024

Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data.

Issue Release: 2024

An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder.

Issue Release: 2024

Bohemian Rhapsody of Future Drug Delivery Systems: Rational Changes Necessary for the Next Revolution.

Issue Release: 2024

In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide).

Issue Release: 2024

Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery.

Issue Release: 2024

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

Issue Release: 2024

Acceptability of Event-Driven and Long-Acting HIV Pre-Exposure Prophylaxis Formulations Among Transgender Women Engaged in Street-Based Sex Work in Baltimore, Maryland.

Issue Release: 2024

Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study.

Issue Release: 2024

Continuous Microfluidic Antisolvent Crystallization as a Bottom-Up Solution for the Development of Long-Acting Injectable Formulations.

Issue Release: 2024

Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy.

Issue Release: 2024

My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.

Issue Release: 2024

Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-world Data for the 1-Month and 3-Month Formulations.

Issue Release: 2024

The FASTER-BUP Study, Extended-Release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose: Protocol for an Observational Prospective Study.

Issue Release: 2024

What are the complications?

What is Bovine Tuberculosis?

What are Host-Pathogen Interactions?

What is a Monogamous Relationship?

Can Condoms Be Used with Other Preventive Measures?

What is Public Health?

What Are the Consequences?

What is the global impact of HIV?

What Are the Outcomes of Host-Pathogen Interactions?

What are the Limitations of Serological Tests?

Long Acting Injectable Formulations - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics